ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
8 167,50
-0,26%
Dow Jones
40 003,59
0,34%
DAX
18 704,42
-0,11%
Brent Oil
83,76
0,00%
Bitcoin
67 266,48
0,49%
Registration Strip Icon for alerts Inscrivez-vous pour des alertes en temps réel, un portefeuille personnalisé et des mouvements de marché.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Pulmonx Corporation (LUNG)

  7. Pulmonx Corporation (LUNG) Actualités

LUNG

Pulmonx (LUNG)

Pulmonx Corporation
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:LUNG
DateHeureSourceTitreSymboleSociété
17/05/202422h03Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:LUNGPulmonx Corporation
07/05/202423h44Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:LUNGPulmonx Corporation
06/05/202423h03GlobeNewswire Inc.Pulmonx Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)NASDAQ:LUNGPulmonx Corporation
01/05/202422h05GlobeNewswire Inc.Pulmonx Reports First Quarter 2024 Financial ResultsNASDAQ:LUNGPulmonx Corporation
10/04/202422h05GlobeNewswire Inc.Pulmonx to Report First Quarter 2024 Financial Results on May 1, 2024NASDAQ:LUNGPulmonx Corporation
02/04/202422h05GlobeNewswire Inc.Pulmonx Announces Appointment of Mehul Joshi as Chief Financial OfficerNASDAQ:LUNGPulmonx Corporation
08/03/202402h02Edgar (US Regulatory)Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]NASDAQ:LUNGPulmonx Corporation
29/02/202422h31Edgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:LUNGPulmonx Corporation
27/02/202422h07Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:LUNGPulmonx Corporation
27/02/202402h48Business WirePulmonx meldet Behandlung des ersten Patienten mit dem AeriSeal®-System in der CONVERT-II-ZulassungsstudieNASDAQ:LUNGPulmonx Corporation
27/02/202402h40Business WirePulmonx annonce le traitement du premier patient par système AeriSeal® dans l'essai pivot CONVERT IINASDAQ:LUNGPulmonx Corporation
27/02/202402h39Business WirePulmonx annuncia il trattamento del primo paziente con il sistema AeriSeal® nello studio pivotale CONVERT IINASDAQ:LUNGPulmonx Corporation
26/02/202414h00Business WirePulmonx Announces Treatment of the First Patient with the AeriSeal® System in CONVERT II Pivotal TrialNASDAQ:LUNGPulmonx Corporation
22/02/202422h31Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:LUNGPulmonx Corporation
21/02/202422h06GlobeNewswire Inc.Pulmonx Reports Fourth Quarter and Full Year 2023 Financial ResultsNASDAQ:LUNGPulmonx Corporation
21/02/202422h05GlobeNewswire Inc.Pulmonx Announces Retirement of CEO Glen French and Appointment of Industry Veteran Steve Williamson as President and Chief Executive OfficerNASDAQ:LUNGPulmonx Corporation
14/02/202412h17Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:LUNGPulmonx Corporation
07/02/202422h05GlobeNewswire Inc.Pulmonx to Report Fourth Quarter and Full Year 2023 Financial Results on February 21, 2024NASDAQ:LUNGPulmonx Corporation
11/12/202315h00GlobeNewswire Inc.The Honest Company Announces Appointment of Michael Barkley, Alissa Hsu Lynch, and Andrea Turner to the Board of DirectorsNASDAQ:LUNGPulmonx Corporation
15/11/202322h05GlobeNewswire Inc.Pulmonx to Present at the Piper Sandler 35th Annual Healthcare ConferenceNASDAQ:LUNGPulmonx Corporation
03/11/202321h04Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:LUNGPulmonx Corporation
31/10/202321h05GlobeNewswire Inc.Pulmonx to Participate at Upcoming Investor ConferencesNASDAQ:LUNGPulmonx Corporation
30/10/202321h05GlobeNewswire Inc.Pulmonx Reports Record Third Quarter 2023 Financial ResultsNASDAQ:LUNGPulmonx Corporation
19/10/202322h38Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:LUNGPulmonx Corporation
16/10/202322h05GlobeNewswire Inc.Pulmonx to Report Third Quarter 2023 Financial Results on October 30, 2023NASDAQ:LUNGPulmonx Corporation
10/10/202322h05GlobeNewswire Inc.Pulmonx Announces CFO Transition and Record Preliminary Third Quarter 2023 RevenueNASDAQ:LUNGPulmonx Corporation
02/08/202322h05GlobeNewswire Inc.Pulmonx Reports Second Quarter 2023 Financial ResultsNASDAQ:LUNGPulmonx Corporation
26/07/202322h05GlobeNewswire Inc.Pulmonx to Present at the Canaccord Genuity 43rd Annual Growth ConferenceNASDAQ:LUNGPulmonx Corporation
17/07/202314h00GlobeNewswire Inc.Pulmonx to Report Second Quarter 2023 Financial Results on August 2, 2023NASDAQ:LUNGPulmonx Corporation
21/06/202300h08Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:LUNGPulmonx Corporation
 Showing the most relevant articles for your search:NASDAQ:LUNG

Dernières Valeurs Consultées

TSXV
APR
TSX
TA.PR.D
TransAlta
BIT
UC528K
Unicredit Bank
BIT
UC5CCQ
Unicredit Bank
TSX
ZWEN
BMO Covered Call Energy ...
BOV
A2RE34M
Ares Management
ASX
S32BOR
COIN
HMGBTC
HI MINT GOLD
BOV
RPAD3Q
ALFA ON
TSXV
FRM.P
Freeform Capital Partners
LSE
91XN
Sg Issuer 27
BMF
DIFN26V26
DIFN26V26 - 07/2026
COIN
GBXEUR
AMEX
ENA
LSE
DFIJ
Dfi Retail
COIN
GHOUSD
Gho Token
Delayed Upgrade Clock
ADVFN Logo

France
Société
Entreprise
Popular
Obtenir l'application

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés